Advertisement Pharmaceutical Business review - Page 3459 of 5283 -
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
July 29, 2026

Eisai and CORE Biomedicine agree on global licence for oncology pipeline

Japanese company Eisai has entered an exclusive global licensing agreement with CORE Biomedicine for several preclinical oncology programmes.

Continue
CORE Biomedicine plans to use the assets to support its precision medicine strategy. Credit: THICHA SATAPITANON / Shutterstock.com.
July 29, 2026

FDA grants fast track designation for HAYA Therapeutics’ HTX-001

By targeting WISPER in cardiac myofibroblasts, HTX-001 is intended to facilitate the precise reprogramming of the fibrotic and pathological cell states. Credit: NMK-Studio / Shutterstock.com.
July 28, 2026

BioMarin and n-Lorem partner on early research for ReNU syndrome therapy

ReNU syndrome affects cognitive, language, and adaptive behavioural development. Credit: NMK-Studio / Shutterstock.com.

Contracts

January 23, 2025

Kamada to supply immune globulin products in Latin America

KAMRAB must be administered alongside a complete rabies vaccine regimen. Credit: Nappy on Unsplash.

Bavarian Nordic secures $156.8m US vaccine deal

Boehringer Ingelheim receives EC conditional marketing approval for spesolimab

Marinus Pharmaceuticals signs collaboration agreement with Tenacia Biotechnology

Deals

Deals January 20, 2025

Fermion and Simcere to partner on development of pain treatment drug

Pharmaceutical Business Review

WuXi Biologics and Sino Biopharm collaborate on monoclonal antibody discovery

Merck enhances ophthalmology portfolio with EyeBio acquisition

Biocon signs licensing and supply deal for diabetes drug in Brazil

Popular

  1. argenx signs agreement to buy Forte Biosciences for $2.2bn
  2. Biointron introduces RushData platform for AI-driven antibody discovery
  3. Kenvue’s Tylenol with Naproxen gains FDA approval
  4. BeOne to invest $300m in US manufacturing facility expansion
  5. FDA grants fast track designation for Lundbeck’s Lu AH69593

PRESS RELEASES

SCHOTT Pharma Invests in Sterile Cartridge Production in Hungary
SCHOTT Pharma Invests in Sterile Cartridge Production in Hungary
SCHOTT Pharma Expands Ready-to-Use Portfolio with Sterile 1.5ml Cartridge
SCHOTT Pharma Expands Ready-to-Use Portfolio with Sterile 1.5ml Cartridge
Dr Imre Molnár Awarded With an Exceptional Scientific Honour – Tswett-Nernst European Award
Dr Imre Molnár Awarded With an Exceptional Scientific Honour – Tswett-Nernst European Award
HPLC 2025 in Bruges: Sharing Advanced Modelling Methods
HPLC 2025 in Bruges: Sharing Advanced Modelling Methods
Dr Imre Molnár Met Professor Ugur Sahin in Berlin, Laureate of the German National Prize, Together With His Wife Professor Özlem Türeci
Dr Imre Molnár Met Professor Ugur Sahin in Berlin, Laureate of the German National Prize, Together With His Wife Professor Özlem Türeci

Suppliers

Whitepapers

Smoothly Through the Production Process: EVERIC™ Strong/Smooth Test
Smoothly Through the Production Process: EVERIC™ Strong/Smooth Test
Strengths and Weaknesses of Different Prefilled Syringes for Injections in Hospitals: A Case Study by Niklas Niederwieser and Patrick Gallagher SCHOTT AG
Strengths and Weaknesses of Different Prefilled Syringes for Injections in Hospitals: A Case Study by Niklas Niederwieser and Patrick Gallagher SCHOTT AG
Tracking the Cracking: How to Optimise Pharma Fill-and-Finish Processes by Use of Strength Testing and Fractography
Tracking the Cracking: How to Optimise Pharma Fill-and-Finish Processes by Use of Strength Testing and Fractography